Searchable abstracts of presentations at key conferences in endocrinology

ea0050p280 | Neuroendocrinology and Pituitary | SFEBES2017

Pituitary radiotherapy causes increased, cardio- and cerebrovascular morbidity, and high Age Standardized Mortality Ratio (ASMR): single centre experience

Jones Alistair , O'Kane Emma , Kieffer Nikki , Bremner Emma , Bhake Ragini , Levy Miles , Reddy Narendra

Background: Pituitary radiotherapy (RT) is known to have metabolic, cardiovascular and cerebrovascular complications due to the effects of radiation on normal pituitary tissue and surrounding neurological structures.Objectives: Retrospective evaluation of effects of RT on pituitary dysfunction, type 2 diabetes mellitus, cardio- and cerebrovascular morbidity and mortality in unselected consecutive pituitary adenomas ...

ea0050p370 | Reproduction | SFEBES2017

High prevalence of multimorbidity in overweight and obese women with Polycystic Ovary Syndrome (PCOS)

Mani Hamidreza , Chudasama Yogini , Bodicoat Danielle , Levy Miles , Gray Laura , Howlett Trevor , Khunti Kamlesh , Davies Melanie

Background: Multimorbidity, presence of 2 or more chronic conditions, is a growing issue for patients as well as health systems. Reported prevalence of multimorbidity in females in a UK study was 23%. Presence of an additional chronic condition adds challenges to an existing condition. The difficulties of living with polycystic ovary syndrome (PCOS) have been well described both in terms of dealing with the symptoms as well as the potential metabolic and men...

ea0050ep026 | Bone and Calcium | SFEBES2017

Parathyroid Cysts – An Unusual Cause for Primary Hyperparathyroidism

Gohil Shailesh , Vimal Venugopal , Sim Sing , Kong Marie-France , Levy Miles

We present two patients with an unusual cause of primary hyperparathyroidism.A 50 year old man was referred due to incidentally noted raised serum calcium consistent with primary hyperparathyroidism (adjusted calcium 3.52 mmol/L, phosphate 0.66 mmol/L, PTH (parathyroid hormone) 99.5 pmol/L, Vitamin D 46 nmol/L). An initial neck ultrasound demonstrated a 1.2x1.7 cm left sided presumed parathyroid nodule but also a cystic 3.3x3.2x1.7...

ea0050ep033 | Bone and Calcium | SFEBES2017

Vitamin D Toxicity & Undetectable Serum Levels – A Conundrum

Venugopal Vimal , Levy Miles J , Reddy Narendra L , Rahman Faizanur , Bhake Ragini C

59 year old woman with relapsing remitting multiple sclerosis (MS), not under Neurology follow-up was privately consulting a nutritionist based in Ireland and following the Coimbra protocol1 since December 2016. This included colecalciferol (1000-170000 IU/ day), vitamin B-complex and trace elements. Dose adjustments were advised during weekly skype consultations based on blood tests (via General Practitioner) and symptoms.<p class="abstex...

ea0050ep057 | Neoplasia, Cancer and Late Effects | SFEBES2017

Cardiac Paraganglioma associated with SDHB mutation and elevated 3-methoxytyramine levels

O'Kane Emma , Jones Alistair , Barwell Julian , Bhake Ragini , Reddy Narendra , Levy Miles

Case: We report a rare case of a primary cardiac paraganglioma. A 49-year-old male was found to have elevated3-methoxytyramine (3-MT) levels with normal metanephrines, having undergone a screening test following discovery of SDHB gene mutation, after his 10-year-old niece developed a phaeochromocytoma.The patient demonstrated no hypertension and did not bear signs of catecholamine excess, but on direct questioning...

ea0050ep070 | Neuroendocrinology and Pituitary | SFEBES2017

Tolosa hunt syndrome: a rare cause of hypopituitarism

Jones Alistair , O'Kane Emma , Keifer Nikki , Bremner Emma , Bhake Ragini , Levy Miles , Reddy Narendra

Introduction: Tolosa Hunt Syndrome (THS) is a steroid-responsive idiopathic inflammatory condition affecting cavernous sinus and/or orbital apex causing painful ophthalmoplegia. We present a rare case of THS resulting in hypopituitarism.Case: 45-year-old female presented with 10-day history of headache, periorbital pain and diplopia. Past medical history included bipolar disorder and bilateral below knee amputation ...

ea0050ep079 | Neuroendocrinology and Pituitary | SFEBES2017

Siadh associated with neuromyelitis optica involving hypothalamus

Papamargaritis Dimitris , Levy Miles J , Reddy Narendra L , Bhake Ragini C

A 21 year old Asian woman presented with relapse of Neuromyelitis Optica (NMO) spectrum disorder, diagnosed aged 16. She had headache, dizziness, right hand weakness and severe hyponatraemia (serum sodium [Na+] 116 [135–145]). Emesis, dominant in previous relapses, was absent – she was euvolaemic. Serum (Seosm) and urine (Uosm) osmolalities were 250 and 468 mosm/kg respectively, thyroid function ...

ea0086cc1 | Featured Clinical Case Posters | SFEBES2022

Case report: a rare case of hypoparathyroidism, deafness and renal dysplasia (HDR) syndrome due to heterozygous pathogenic GATA3 alteration

Shafiq Shahriar , Gohil Shailesh , Bhake Ragini , Reddy Narendra , Craft Emily , Lakhani Neeta , Levy Miles

Introduction: Hypoparathyroidism may be an isolated or a component of a complex syndrome. Although genetic disorders are not the most common cause, molecular analyses have identified a growing number of genes that when defective result in impaired formation of the parathyroid glands, disordered synthesis or secretion of parathyroid hormone.Case presentation: We are reporting a 37-year-old gentleman, who is the first adult case diagnosed at our University...

ea0086p47 | Endocrine Cancer and Late Effects | SFEBES2022

A Rare Occurrence of Phaeochromocytoma in an Adult with Previously Diagnosed Wilms Tumour - Case Report

Al Jumaah Ali , Gohil Shailesh , Levy Miles J , Reddy Narendra L , Bhake Ragini

Introduction: Phaeochromocytoma affects <1:100000 people per year. Wilms tumour (WT) affects almost 1:10000 children each year. Both tumours are associated with somatic genetic alterations: Phaeochromocytoma (RET, VHL, NF1, SDHA, SDHAF2, SDHB, SDHC, SDCD, TMEM127 and MAX); WT (WT1, 11p13, 11p15, tp53, NSD1, KDM3B, BRCA2). Both tumours affecting the same person have only been reported twice in the literature.Case Report: We report a lady who, at the a...

ea0065p31 | Adrenal and Cardiovascular | SFEBES2019

The PASS score is not a reliable measure of predicting aggressive potential in phaeochromocytoma – experience over 14 years at our University Teaching Hospital

Gohil Shailesh , Seehra Jaspreet , Chauhan Vishnusai , Richards Catherine , Lloyd David , Bhake Ragini , Bhardwaj Neil , Levy Miles

Background: The phaeochromocytoma of the adrenal gland scaled score (PASS) is used for histological reporting of phaeochromocytomas as a surrogate marker of malignant potential. A PASS score of ≥4 (of a maximum of 20) suggests an aggressive tumour and hence the importance of lifelong careful follow-up. However, the utility of the PASS score has been questioned recently due to the discordance between PASS score and clinical outcomes.Aim: To review t...